Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Marc Rubin


  • Director at Galectin Therapeutics Inc (GALT), 2017-12-08
  • Director at Curis Inc (CRIS), 2017-11-16
  • Executive Chairman at Titan Pharmaceuticals Inc (TTNP), 2017-02-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
GALT $1.85 7,000 Director 55,581 2017-12-08 Filing
GALT $1.85 7,000 Director 55,581 2017-12-08 Filing
CRIS $0.98 25,000 Director 51,596 2017-11-16 Filing
TTNP $3.25 5,000 Officer, Director 156,317 2016-01-11 Filing
TTNP $0.72 50,000 Officer, Director 832,200 2015-08-28 Filing